Participant perspectives on management and communication of incidental findings identified on radiographic imaging performed during a clinical research trial: A single site pilot study
Allie R. Walpert, Carolyn Dunderdale, Suman Srinivasa , Sara E. Looby
{"title":"Participant perspectives on management and communication of incidental findings identified on radiographic imaging performed during a clinical research trial: A single site pilot study","authors":"Allie R. Walpert, Carolyn Dunderdale, Suman Srinivasa , Sara E. Looby","doi":"10.1016/j.conctc.2024.101305","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Incidental findings (IFs) in radiographic imaging are unexpected discoveries unrelated to the purpose of the scan. While the protocol for communicating IFs is better defined for clinical providers, little formal guidance on communicating IFs identified on research scans to participants is available. This study explored participants’ experience with communication and management of IFs found on imaging identified in a clinical research trial.</p></div><div><h3>Methods</h3><p>Participants who completed the parent clinical trial, which included imaging, were invited to participate. A survey, developed by the study team, was administered telephonically, and consisted of multiple choice and open-ended questions.</p></div><div><h3>Results</h3><p>Thirty participants enrolled in the survey study. Ninety-three percent of all participants (with and without IFs) reported they would participate in another research study to learn information that was important to their health. Seventeen participants reported being notified about an IF on their study scan(s). Ninety-four percent of those participants with an IF were satisfied with how the IF was communicated, and 71 % were grateful to find out about a health problem before it became an issue. Forty-one percent reported that learning about the IF led to improved health. Content analysis of the data from the open-ended questions revealed categories and themes which enriched the quantitative data.</p></div><div><h3>Conclusion</h3><p>Participants generally wanted to know when an IF was discovered unexpectedly on their imaging scan, as they learned important information about their health. Findings underscore the importance of having a clear protocol for communicating IFs to research study participants that undergo evaluation with radiographic imaging.</p></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"39 ","pages":"Article 101305"},"PeriodicalIF":1.4000,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2451865424000528/pdfft?md5=8d80d1568e7f0f4ebaf09ae7b5b5847e&pid=1-s2.0-S2451865424000528-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary Clinical Trials Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451865424000528","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Incidental findings (IFs) in radiographic imaging are unexpected discoveries unrelated to the purpose of the scan. While the protocol for communicating IFs is better defined for clinical providers, little formal guidance on communicating IFs identified on research scans to participants is available. This study explored participants’ experience with communication and management of IFs found on imaging identified in a clinical research trial.
Methods
Participants who completed the parent clinical trial, which included imaging, were invited to participate. A survey, developed by the study team, was administered telephonically, and consisted of multiple choice and open-ended questions.
Results
Thirty participants enrolled in the survey study. Ninety-three percent of all participants (with and without IFs) reported they would participate in another research study to learn information that was important to their health. Seventeen participants reported being notified about an IF on their study scan(s). Ninety-four percent of those participants with an IF were satisfied with how the IF was communicated, and 71 % were grateful to find out about a health problem before it became an issue. Forty-one percent reported that learning about the IF led to improved health. Content analysis of the data from the open-ended questions revealed categories and themes which enriched the quantitative data.
Conclusion
Participants generally wanted to know when an IF was discovered unexpectedly on their imaging scan, as they learned important information about their health. Findings underscore the importance of having a clear protocol for communicating IFs to research study participants that undergo evaluation with radiographic imaging.
背景放射成像中的意外发现(IFs)是指与扫描目的无关的意外发现。虽然临床医疗人员对交流 IFs 的协议有了更明确的定义,但几乎没有关于向参与者交流研究扫描中发现的 IFs 的正式指南。本研究探讨了参与者在临床研究试验中发现的成像中发现的 IFs 的沟通和管理经验。方法邀请完成了包括成像在内的母体临床试验的参与者参与研究。研究小组通过电话进行了一项调查,包括多项选择题和开放式问题。93%的参与者(有 IFs 和没有 IFs)表示,他们将参加另一项研究,以了解对其健康重要的信息。有 17 名参与者表示,他们在研究扫描时收到了 IF 通知。在有 IF 的参与者中,94% 的人对 IF 的传达方式表示满意,71% 的人对在健康问题恶化之前就能发现它表示感谢。41%的人表示,通过了解 IF 改善了健康状况。对开放式问题中的数据进行的内容分析揭示了一些类别和主题,这些类别和主题丰富了定量数据。研究结果表明,为接受放射成像评估的研究参与者制定明确的 IF 告知协议非常重要。
期刊介绍:
Contemporary Clinical Trials Communications is an international peer reviewed open access journal that publishes articles pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from a wide range of disciplines including medicine, life science, pharmaceutical science, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics. Contemporary Clinical Trials Communications is unique in that it is outside the confines of disease specifications, and it strives to increase the transparency of medical research and reduce publication bias by publishing scientifically valid original research findings irrespective of their perceived importance, significance or impact. Both randomized and non-randomized trials are within the scope of the Journal. Some common topics include trial design rationale and methods, operational methodologies and challenges, and positive and negative trial results. In addition to original research, the Journal also welcomes other types of communications including, but are not limited to, methodology reviews, perspectives and discussions. Through timely dissemination of advances in clinical trials, the goal of Contemporary Clinical Trials Communications is to serve as a platform to enhance the communication and collaboration within the global clinical trials community that ultimately advances this field of research for the benefit of patients.